Ulrik B. Nielsen's most recent trade in Merrimack Pharmaceuticals Inc was a trade of 7,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 6, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Merrimack Pharmaceuticals Inc | Ulrik B. Nielsen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 7,000 | 28,000 | - | - | Stock Option (right to buy) | |
| Merrimack Pharmaceuticals Inc | Ulrik B. Nielsen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 7,000 | 21,000 | - | - | Stock Option (right to buy) | |
| Merrimack Pharmaceuticals Inc | Ulrik B. Nielsen | Director | Purchase of securities on an exchange or from another person at price $ 4.24 per share. | 24 Jan 2022 | 14,287 | 36,968 (0%) | 0% | 4.2 | 60,630 | Common Stock |